Tagged with IT

Switzerland After a Moderna-Lonza production site and a Merck manufacturing facility were set up in western Switzerland, the country continues to attract big pharma capital with a CHF 200 million investment from Takeda. “Switzerland is a globally recognized hotspot for biopharma companies. As such, it naturally attracts investments. Our role is…

UAE Taher Shams, Zulekha Healthcare Group’s Managing Director, outlines the group’s expansion in UAE and India and its participation in the Dubai Health Authority’s “Dubai Health Experience” medical tourism portal. In addition, he speaks about fears of market saturation in UAE.  We are the shining star in the Middle East, with…

United Kingdom US biotech Moderna – producer of a messenger RNA (mRNA) COVID-19 vaccine that has found its way into 75 million arms in the US alone and generated USD 12 billion in profit for the firm last year – has announced a new GBP one billion investment into a UK manufacturing…

Italy Domenico Mantoan, General Manager of AGENAS, the Italian National Agency for Regional Health Services, discusses the role of the agency in Italy’s decentralised healthcare system, the National Recovery and Resilience Plan’s aim to improve territorial inequalities, and the National Outcomes Program managed by AGENAS on behalf of the Ministry of…

Italy Nicoletta Luppi, MSD Italia’s Senior Vice President & Managing Director details the need for healthcare reform in Italy and walks us through MSD’s portfolio priorities. In addition, she explains the Italian affiliate’s Equity and Inclusion initiatives.  Since the Organon spinoff, the strategy to focus on specific parts of the portfolio…

Italy In recent years, since the adoption of a law assuring its citizens’ right to access palliative care, Italy has given increased attention to pain management. According to Aldo Sterpone, Italy General Manager at Grünenthal, a company especially focused on the area of pain, there is still a lot of work…

Italy Aldo Sterpone, Grünenthal Italia’s General Manager, outlines the company’s focus on pain and its efforts to bring innovation to the area through R&D and acquisitions. He also explains the importance of Italy as one of Grünenthal’s manufacturing hubs. We are one of the few companies focusing heavily on pain. There…

Italy We spoke with Luca Crippa, CEO and Managing Director at IBSA Farmaceutici, about the company’s approach to developing new delivery technologies for existing and natural molecules, its focus on endocrinology, fertility, orthopaedics and aesthetic medicine, and the group’s new affiliates in the US, France, Germany and the UK. … the…

Italy Stevanato Group’s CEO & COO, Franco Moro explaines how the over 70-year-old provider of  containment and delivery solutions went public and as an established player in the vaccine space managed to service large pharmaceutical companies during the pandemic. He also speaks about the company’s move towards further internationalisation. … the…

United Kingdom After several scandals that revealed longstanding deficiencies and a continual churn of executive staff, a recent independent review of leadership in the National Health Service (NHS) has uncovered a lack of consistency and coordination as well as cases of discrimination within the system. As a result of the report, the…

Italy CAI is an engineering service company. Its regional manager for South Europe, Andrea Castiglioni, comments on the pharma industry’s need for commissioning and qualification services when looking to reduce time to market or set up new production facilities. He also outlines the role of CAI in helping companies who produce…

Italy Merck Italia’s Managing Director & President, Jan Kirsten explains the importance of the Italian affiliate within the global organisation, Merck’s aim to strengthen its position in oncology and the challenges of fertility in a country with one of the lowest birthrates in the world. [In Italy] we have the full…